LIFECORE BIOMEDICAL, INC. Total Long-Term Debt
LIFECORE BIOMEDICAL, INC. (LFCR) had Total Long-Term Debt of $155.07 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2026-08-05
- 2026-06-30: Long-term Debt $155.07M.
- 2026-03-31: Long-term Debt $148.74M.
- 2025-12-31: Long-term Debt $142.24M.
- 2025-09-30: Long-term Debt $135.95M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2026-06-30 | $155.07M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $148.74M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $142.24M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $135.95M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $130.44M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $124.94M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $111.30M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $106.32M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $124.67M 10-KT · filed 2026-03-16 | $101.59M 10-K · filed 2024-08-26 |
| 2024-02-25 | $97.11M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $92.86M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $88.83M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $84.84M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $98.96M 10-Q · filed 2023-06-02 | |
| 2022-11-27 | $98.95M 10-Q · filed 2023-03-16 | |
| 2022-08-28 | $98.57M 10-Q/A · filed 2023-03-16 | |
| 2022-05-29 | $98.18M 10-K · filed 2024-03-20 | |
| 2022-02-27 | $79.60M 10-Q · filed 2022-04-07 | |
| 2021-11-28 | $124.19M 10-Q · filed 2022-01-07 | |
| 2021-08-29 | $123.83M 10-Q · filed 2021-10-05 | |
| 2021-05-30 | $164.90M 10-K/A · filed 2023-03-16 | |
| 2021-02-28 | $145.05M 10-Q · filed 2021-04-08 | |
| 2020-11-29 | $93.19M 10-Q · filed 2021-01-07 | |
| 2020-08-30 | $104.95M 10-Q · filed 2020-10-07 | |
| 2020-05-31 | $112.92M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $116.26M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $119.19M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $94.54M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $96.98M 10-K · filed 2020-08-14 | |
| 2019-02-24 | $99.43M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $39.83M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $41.06M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $42.30M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $43.53M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $44.77M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $46.00M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $47.24M 10-K · filed 2018-08-09 | |
| 2017-02-26 | $48.47M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $49.71M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $52.00M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $53.84M 10-K/A · filed 2018-03-15 | $54.66M 10-K · filed 2016-08-01 |
| 2016-02-28 | $57.15M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $48.21M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $40.60M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $42.52M 10-K · filed 2016-08-01 | |
| 2015-03-01 | $40.49M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $42.23M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $40.03M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $34.37M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $35.78M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $37.18M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $38.92M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $40.30M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $42.84M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $44.23M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $45.95M 10-Q/A · filed 2013-01-02 | |
| 2012-05-27 | $47.32M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |